Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy.
- DOI
- 10.1007/s00415-026-13711-6
- Published
- 2026-03-03
- Container
- J Neurol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00415-026-13711-6,
title = {Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to \< 18-year-old boys with duchenne muscular dystrophy.},
author = {Lochmüller H and Gonorazky H and Nigro E and Mah JK and Alemán A and Yaworski A and Oskoui M and Sbrocchi AM and Selby K and de Vera A and McAdam L and Gresko E and Linden A and Dutreix C and Hoffman EP.},
year = {2026},
journal = {J Neurol},
doi = {10.1007/s00415-026-13711-6},
url = {https://doi.org/10.1007/s00415-026-13711-6}
}RIS
TY - JOUR TI - Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy. AU - Lochmüller H AU - Gonorazky H AU - Nigro E AU - Mah JK AU - Alemán A AU - Yaworski A AU - Oskoui M AU - Sbrocchi AM AU - Selby K AU - de Vera A AU - McAdam L AU - Gresko E AU - Linden A AU - Dutreix C AU - Hoffman EP. PY - 2026 JO - J Neurol DO - 10.1007/s00415-026-13711-6 UR - https://doi.org/10.1007/s00415-026-13711-6 ER -
APA
H, L., H, G., E, N., JK, M., A, A., A, Y., M, O., AM, S., K, S., A, D. V., L, M., E, G., A, L., C, D., & EP., H. (2026). Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy.. J Neurol. https://doi.org/10.1007/s00415-026-13711-6
Source records
- europe-pmc · retrieved 2026-09-26T05:22:12.081Z